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Introduction
Lung transplantation (LT) is indispensable for patients 
with progressive pulmonary hypertension (PH) despite 
optimized medical therapy (1,2). However, patients with 
primary PH are at a higher risk of developing primary 
graft dysfunction (PGD), as well as show higher 30-day 
and 90-day mortality rates, after LT than patients with 
other pulmonary diseases undergoing LT (3-5). Moreover, 
patients with secondary PH, who have mean pulmonary 
arterial pressure (PAP) values of ≥25 mmHg secondary to 
underlying lung diseases, are also at an elevated risk of PGD 
and decreased long-term survival (6,7). Most patients with 
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PH require cardiopulmonary support, such as with veno-
arterial extracorporeal membrane oxygenation (ECMO) and 
cardiopulmonary bypass (CPB), during LT, as they cannot 
tolerate hemodynamically during single-lung perfusion after 
hilar clamping (8). Consequently, the use of anticoagulation 
for cardiopulmonary support could increase the risk of 
massive hemorrhage and the need for massive fluid infusion 
and blood/blood product transfusion during LT, which 
increases the risk of development of PGD after LT (9). 
In the patients with primary PH, the elevated pulmonary 
pressure has been shown to cause neovascularization of 
the vasa vasorum and remodeling of the collateral vessels 
in the perihilar mediastinal pleura (10-15). Unintentional 
injury of the collateral vessels in the perihilar mediastinal 
pleura, consequent to their becoming less visible due to 
the decreased blood flow during cardiopulmonary support, 
could result in uncontrollable bleeding during LT in 
patients with PH. In fact, postoperative blood loss within 
24 hours of LT has been reported to be significantly higher 
in patients with PH than in those with other diseases (16). 
To decrease the blood loss during LT in patients with PH, 
preventive closure of collateral vessels in the perihilar 
mediastinal pleura might be useful, especially in patients 
undergoing LT under cardiopulmonary support. However, 
the effect of preventive closure of collateral vessels in the 
perihilar mediastinal pleura during LT in patients with 
PH remains to be clearly determined. We hypothesized 
that a higher number of hemoclips are required to attain 
meticulous hemostasis in the patients with primary PH as 
compared to those with secondary PH or non-PH. The 
purpose of this study was to examine the effect of preventive 
closure of collateral vessels in the perihilar mediastinal 
pleura using hemoclips on the risk of intraoperative 
bleeding and outcomes of LT in patients with and without 
primary or secondary PH. We present the following article 




This was a single-center retrospective cohort study 
conducted at Okayama University Hospital between 
February 2008 and August 2015. A total of 85 patients who 
had undergone LT were included in this study; however, 5 
patients who underwent repeat transplantation during the 
study period were excluded from this study. The remaining 
80 recipients, including 27 recipients of living-donor lobar 
LT (LDLLT) and 53 recipients of cadaveric LT (CLT), 
were divided into the following three groups: patients with 
primary PH (primary PH group, N=13), patients with 
secondary PH (secondary PH group, N=29), and patients 
without PH (non-PH group, N=38) (Figure 1). The primary 
PH group included patients with pulmonary arterial 
hypertension (PAH, N=8), pulmonary veno-occlusive 
disease (PVOD, N=3), and chronic thromboembolic 
pulmonary hypertension (CTEPH, N=2). Patients with 
mean PAP values of ≥25 mm Hg resulting from underlying 
lung diseases were defined as having secondary PH. This 
protocol of this retrospective study (No. 2008-011) was 
approved by the Institutional Review Board of Okayama 
University Hospital. Informed consent was obtained in the 
form of opt-out on the website. The study was conducted 
in accordance with the Declaration of Helsinki (as revised 
in 2013).
The preoperative and intraoperative characteristics and 
postoperative outcomes were compared among the three 
groups. The lung allocation score (LAS) was calculated to 
assess the preoperative disease severity in the recipients (17), 
using the LAS calculator published on the OPTN website 
(https://optn.transplant.hrsa.gov/resources/allocation-
calculators/lascalculator/). The maximum total number of 
HLA mismatches could equal 12 in cases of LDLLT, because 
LDLLT involves two different donors for each recipient (18). 
The prognostic nutrition index (PNI) was calculated using the 
following equation: PNI = [10 × serum albumin (g/dL)] + [0.005 
× total lymphocyte count (/mm3)] (19). The preoperative 
mean PAP was assessed by right-heart catheterization 
immediately after the induction of general anesthesia for 
LT. CPB was exclusively used for cardiopulmonary support 
during LT. The graft ischemic time was defined as the 
ischemic time up to the second LT. The total transfusion 
volume was calculated from the amounts of packed red 
blood cells (RBC), fresh-frozen plasma (FFP), and platelet 
concentrates (PC) administered during the operation. 
The PGD grades in the patients were assigned according 
to the definition of PGD proposed by the International 
Society for Heart and Lung Transplantation (ISHLT) (20). 
Chronic lung allograft dysfunction (CLAD) was diagnosed 
by a decline of the forced expiratory volume in 1 s (FEV1) 
to <80% of the baseline; The FEV1 was calculated as the 
average of the two best FEV1 values obtained at least 
3 weeks apart, according to the classification system 
proposed by the ISHLT (21). In addition, subgroup analysis 
for total amount of blood loss was performed according to 
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primary PH subcategories: PAH, PVOD, and CTEPH. 
Also, subgroup analysis for total number of hemoclips and 
total amount of blood loss was performed in the patients of 
secondary PH with and without bronchiectasis.
The technique of closure of collateral vessels in the perihilar 
mediastinal pleura with hemoclips and the method of 
counting of hemoclips
Hilar dissection was routinely performed before the 
establishment of CPB prior to the LT. During the hilar 
dissection, collateral vessels in the perihilar mediastinal 
pleura containing the circumferential connective and 
adipose tissue around the hilar structures, including the 
pulmonary artery, the pulmonary vein and the main 
bronchus as well as the bronchial arteries, lymph nodes, 
pleural adhesions and the pulmonary ligament, were 
meticulously closed with hemoclips (Weck® horizon™ 
metal ligation system, Teleflex Medical, North Carolina, 
USA) (Figure 2). After closure of the central collateral 
vessels using hemoclips, the peripheral collateral vessels 
were divided by electrocautery.
The total number of hemoclips were retrospectively 
counted on frontal-view chest X-ray images obtained after 
the LT by two surgeons (H.Y. and K.I.), and the average of 
two values determined by the examiners was used for the 
analysis in this study (Figure 3A,3B). The contrast of X-ray 
images was adjusted to enhance the hemoclip metal during 
the counting. 
Statistical analysis
All statistical analyses were performed using EZR version 
1.40 (Saitama Medical Center, Jichi Medical University, 
Saitama, Japan), which is a graphical user interface for R 
version 3.5.2 (The R Foundation for Statistical Computing, 
Vienna, Austria). Specifically, the software is a modified 
version of R commander, designed to add statistical 
functions frequently used in biostatistics (22). GraphPad 
Prism 7.04 software program (San Diego, CA, USA) was 
used for graph editing. Differences in patient characteristics 
between any two groups were tested by the Pearson’s chi-
square test for categorical variables and by the Kruskal-
Wallis test for continuous variables. The Bonferroni 
correction was employed for multiple comparisons 
(primary PH vs. secondary PH, primary PH vs. non-PH, 
and secondary PH vs. non-PH). The overall survival and 
CLAD-free survival were analyzed using the Kaplan-Meier 
method, and differences among the groups were compared 
by the log-rank test. Subgroup analysis for total amount 
of blood loss in primary PH subcategories was tested by 
the Kruskal-Wallis test and Bonferroni correction was 
employed for multiple comparisons (PAH vs. PVOD, PH 
vs. CTEPH, and PVOD vs. CTEPH). Subgroup analysis 
Figure 1 Flow-diagram of this study cohort. Lung Transplantation was performed in 85 patients during the study period; of these, five 
patients who underwent repeat transplantation were excluded from this study. The remaining 80 patients were divided into 3 groups 
according to the diagnosis of primary or secondary PH, as follows: primary PH group (N=13), secondary PH group (N=29), and non-PH 
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for total number of hemoclips and total amount of blood 
loss in the patients of secondary PH with and without 
bronchiectasis was performed by Mann-Whitney U test. 
Differences at P<0.05 (two-sided) were considered as being 
significant. Missing data were not replaced.
Results
Table 1 shows the preoperative patient characteristics. 
Interstitial lung disease (58.6%) was the most frequent 
cause of secondary PH in the secondary PH group. 
Although 69% of the patients in the primary PH group had 
received preoperative epoprostenol therapy, no significant 
differences in the preoperative platelet count were noted 
among the three groups. While the LAS in the primary PH 
group was similar to that in the secondary PH group, that 
in the secondary PH group was significantly higher than the 
value in the non-PH group (P=0.032). Unsurprisingly, the 
mean PAP values in the primary PH group (P=0.0074) and 
secondary PH group (P=0.00019) were significantly higher 
than the mean PAP in the non-PH group. 
As shown in Table 2, single LDLLT was performed 
in two patients of the primary PH group, while in the 
secondary PH group, single CLT was performed in 
three patients and single LDLLT in one patient. The 
operative time (P=0.0070), total ischemic time (P=0.041) 
and duration of CPB (P=0.013) in the secondary PH 
group were significantly longer than those in the non-
PH group. The rates of intraoperative CPB use did not 
differ among the three groups. Of note, the total number 
of hemoclips in the primary PH group was significantly 
higher than that in the secondary PH group (P=0.0060) 
Figure 2 Intraoperative photographs and illustrations of preventive closure of collateral vessels in the perihilar mediastinal pleura using 
hemoclips. The collateral vessels on the left superior pulmonary vein were closed with hemoclips (A) and divided by electrocautery (B). 
A B
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or the non-PH group (P=0.0045) (Figure 3C). There was 
no significant difference in the amount of intraoperative 
blood loss in the subclassification of primary PH (P=0.19; 
PAH vs. PVOD, P=0.99; PAH vs. CTEPH, P=0.53; PVOD 
vs. CTEPH, P=0.99). Although the patients of secondary 
PH with bronchiectasis had significantly higher amount 
of intraoperative blood loss (P=0.038) than those without 
bronchiectasis, the number of hemoclips did not differ 
(P=0.23). By contrast, there was no significant difference in 
the volume of blood loss or total volume of transfusion of 
RBC, FFP, and PC during the LT among the three groups.
The postoperative outcomes are shown in Table 3. In a 
three-group comparison, the postoperative ECMO support 
rate was significantly higher in the primary PH group 
(P=0.019). Early outcomes after the LT in terms of the 
maximum grade of PGD, and incidences of acute rejection 
and antibody-mediated rejection were not statistically 
significantly different among the three groups. Also, 
30- and 90-day mortality were similar among the three 
groups. The overall survival in the primary PH group was 
comparable to that in the secondary PH group (P=0.99) 
and the non-PH group (P=0.37), whereas the overall 
survival in the secondary PH group was significantly worse 
than that in the non-PH group (Figure 4A, P=0.041). The 
CLAD-free survival rates did not differ among the three 
groups (Figure 4B). 
Discussion
In this study, we found that the total number of hemoclips 
needed for preventive closure of the collateral vessels in 
the perihilar mediastinal pleura during LT was significantly 
higher in the primary PH group than in the other two 
groups. By contrast, we found no significant differences 
in other intraoperative variables, postoperative early 
outcomes, including volume of blood loss, the total volume 
of transfusion of RBC, FFP and PC, or 30- and 90-day 
mortality rates among the three groups, except that the 
secondary PH group showed significantly worse survival 
as compared to the non-PH group in the chronic phase. 
Our results suggest that patients with primary PH could 
have more abundant collateral vessels in the perihilar 
mediastinal pleura as compared to patients with other 
diseases undergoing LT; therefore, meticulous closure of 
the collateral vessels in the patients with primary PH could 
contribute to control of intraoperative bleeding despite 
the use of CPB/anticoagulation, and similar outcomes 
to those in patients with other diseases undergoing LT 
could be obtained. To the best of our knowledge, this is 
the first report to examine the effect of preventive closure 
Figure 3 Comparison of the total number of hemoclips on the postoperative frontal-view chest X-ray images. Representative postoperative 
chest X-rays from the non-PH group (A) and primary PH group (B). (C) The total number of hemoclips needed was significantly higher 
in the primary PH group (median 71.5; range, 29.5–199.5) than in the secondary PH group (median 39, range 12–103.5, P=0.0060) and 
the non-PH group (median 46.5; range, 2–127, P=0.0045). Interestingly, there was no significant difference in the number of clips needed 
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of collateral vessels in the perihilar mediastinal pleura on 
the risk of intraoperative bleeding and outcomes of LT in 
patients with PH.
Obviously, patients with primary PH had higher 
preoperative mean PAP values and received preoperative 
epoprostenol therapy more frequently, necessitating use 
of postoperative ECMO at a higher frequency due to 
decreased cardiac function as compared to the non-PH 
group (23). Although preoperative epoprostenol therapy 
causes vasodilation and inhibition of platelet aggregation 
(24-27), resulting in thrombocytopenia and easy bleeding, 
the preoperative platelet counts did not differ significantly 
among the three groups in this study. The high rate of 
interstitial lung disease as the cause of secondary PH could 
be attributed to the long waiting time for CLT, due to the 
severe shortage of donors in Japan (24,25). LT for secondary 
PH has been shown to yield equivalent survival to that for 
non-PH conditions (6); however, we speculated that the 
overall survival in the secondary PH group was worse than 
that in the non-PH group in this study, because the secondary 
PH group had a higher LAS than the non-PH group.
The total number of hemoclips needed was significantly 
higher in the primary PH group than in the other two 
groups, suggesting that the patients with primary PH 
had a higher number of collateral vessels in the perihilar 
mediastinal pleura as compared to the patients with 
secondary PH and patients without PH undergoing LT. 
Our results lend support to the notion that in patients 
with primary PH, hypoxia and endothelin-1 serve as 
potent stimuli for the growth of new vessels, resulting in 
neovascularization of the vasa vasorum and remodeling 
of collateral vessels (10-15). Although we mainly use 
monopolar electrocautery during LT, division of the 
collateral vessels by electrocautery alone is associated with 
the risk of after-bleeding, especially under the condition 
of anticoagulation used for CPB or veno-arterial ECMO, 
which is generally required for LT in patients with primary 
PH (26-29). Recently, veno-arterial ECMO has been 
increasingly utilized as an alternative cardiopulmonary 
support with benefits for post-transplant outcomes (27,28). 
ECMO is theoretically less invasive than conventional 
CPB and reduces the inflammatory response as well as the 
need for full heparinization. CPB use was associated with 
a significantly higher incidence of PGD; however, CPB 
provides safer, easier and more versatile surgical fields 
than ECMO (29). Moreover, meticulous management 
of graft reperfusion flow and low oxygen concentration 
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Table 2 Patient characteristics of the intraoperative variables
Intraoperative 
variables
Primary PH  
N=13









Primary PH vs. 
Secondary PH
Primary PH vs. 
secondary PH vs. 
non-PH
Lung transplant procedure, n (%)
Single 2 (15.4) 4 (13.8) 12 (31.6) 0.99 0.48 0.99 0.18
Bilateral 11 (84.5) 25 (86.2) 26 (68.4)
Operative time (min), 
median [range]
554 [422–690] 571 [257–845] 471 [238–785] 0.097 0.007 0.99 0.0043
Ischemic time (min), 
median [range]
163 [84–683] 532 [82–787] 337 [74–628] 0.99 0.041 0.37 0.041
Cardiopulmonary 
bypass use, yes,  
n (%)
13 (100) 27 (93.1) 29 (76.3) 0.39 0.4 0.99 0.041
Duration of 
cardiopulmonary 
bypass (min), median 
[range]
264 [120–433] 258 [151–565] 231 [115–263] 0.22 0.013 0.99 0.013
Total amount of blood 
loss, ml, median 
[range]
1320 [370–7,620] 1770 [200–15,860] 765 [30–8,800] 0.59 0.12 0.99 0.098
Total amount of RBC, 
ml, median [range]
560 [51.8–5,040] 560 [0–6,720] 560 [0–2,240] 0.85 0.3 0.99 0.22
Total amount of FFP, 
ml, median [range]
1,200 [240–2,880] 720 [0–3,120] 720 [0–2,400] 0.23 0.99 0.99 0.2
Total amount of PC, 
ml, median [range]
400 [200–800] 400 [0–1,000] 400 [0–600] 0.18 0.65 0.99 0.14
PH, pulmonary hypertension; RBC, red blood cells; FFP, fresh-frozen plasma; PC, platelet concentrates.
long-term outcomes of LT using extended criteria donor 
lungs as compared to ECMO (29). For these reasons, we 
had used CPB as the first choice for LT at our institution 
during the study period. In addition to anticoagulant 
therapy, electrocautery dissection of collateral vessels 
while using cardiopulmonary support, when the blood 
pressure is low, might cause rebleeding after normalization 
of the blood pressure following weaning from the 
cardiopulmonary support. To secure hemostasis during LT 
under cardiopulmonary support, we adopted preventive 
closure of the collateral vessels with hemoclips during hilar 
dissection for LT. In addition to the use of electrocautery, 
routine use of hemoclips allowed mechanical closure of 
the mediastinal pleura, securing hemostasis during hilar 
dissection. Furthermore, single lung ventilation using 
double-lumen endotracheal tube can provide working space 
in the surgical field and contribute to hemostasis especially 
of the dorsal portion of the hilum, which could be difficult 
after reperfusion and reventilation of the grafts. At present, 
a vessel sealing system (30), which has excellent hemostatic 
properties, that has been developed to be elaborate enough 
for hilar dissection is available, which might offer the 
potential to secure hemostasis as an alternative method to 
the use of hemoclips. 
While patients with primary PH have been shown to 
have the lowest one-year survival rates after LT, their long-
term survival is similar to the survival of patients with 
cystic fibrosis or alpha-1 antitrypsin deficiency (2,31,32). 
Improvement of the surgical mortality is the key to 
improving the one-year survival after LT in patients with 
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Table 3 Patient characteristics of the postoperative variables
Postoperative variables
Primary PH  
N=13









Primary PH vs. 
Secondary PH
Primary PH vs. 
secondary PH 
vs. non-PH
Postoperative use of 
ECMO, yes, n (%)
3 (23.1) 3 (10.3) 0 0.053 0.46 0.99 0.019
Reoperation due to 
hemorrhage, yes, n (%)
3 (23.1) 6 (20.7) 2 (5.3) 0.56 0.36 0.99 0.11
Maximum grade of PGD  
(0–72 h), median [range]
2 [0–3] 2 [0–3] 1 [0–3] 0.16 0.99 0.12 0.086
Acute rejection, yes, n (%) 4 (30.8) 5 (17.2) 6 (15.8) 0.99 0.99 0.99 0.47
Antibody-mediated 
rejection, yes, n (%)
2 (15.4) 2 (6.9) 1 (2.6) 0.95 0.99 0.99 0.26
Postoperative GERD, yes, n 0 0 0 – – – –
Postoperative maintenance 
hemodialysis, yes, n (%)
2 (15.4) 0 2 (5.3) 0.99 0.99 0.50 0.11
30-day mortality, yes, n 0 0 0 – – – –
90-day mortality, yes, n (%) 0 1 (3.4) 0 – 0.99 0.99 0.41
Time since transplant to 








0.99 0.73 0.99 0.53
PH, pulmonary hypertension; ECMO, extracorporeal membrane oxygenation; PGD, primary graft dysfunction; GERD, gastro esophageal 
reflux disease.
Figure 4 Overall survival and CLAD-free survival rates after lung transplantation. The overall survival rate in the primary PH group was 
comparable to the overall survival rates in the secondary PH group (P=0.99) and the non-PH group (P=0.37), whereas the survival rate in 
the secondary PH group was significantly worse than that in the non-PH group (P=0.041) (A). There were no significant differences in the 

















0         1         2         3         4         5          6
P=0.37, Non-PH vs. primary PH
P=0.041, Non-PH vs. secondary PH









38 37 25 22 18 18 17
13 11 9 8 6 6 5














P=0.99, Non-PH vs. primary PH
P=0.99, Non-PH vs. secondary PH
















38 34 22 17 16 14 14
13 9 9 8 6 5 4
29 22 16 11 11 8 6
B
5667Journal of Thoracic Disease, Vol 13, No 10 October 2021
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2021;13(10):5658-5669 | https://dx.doi.org/10.21037/jtd-21-1119
primary PH. In this study, the maximum grade of PGD, 
the 30-day mortality, the 90-day mortality and the overall 
survival in the primary PH group were similar to the 
corresponding values in the non-PH group. Therefore, the 
control of intraoperative bleeding and blood transfusion 
in patients with primary PH could contribute to similar 
outcomes of LT being obtained in patients with PH as 
compared to those in patients without PH.
Several limitations associated with the present study 
warrant mention. First, this was a retrospective study 
conducted at a single transplant center, and other than 
preventive closure of collateral vessels with hemoclips, 
LT technique might have improved over the years during 
the study period. Although the single transplant team 
performed the limited number of LT in the same manner 
at our institution, the detailed technique could differ 
among the patients. Second, because the number of 
patients was small, especially in the primary PH group, 
there is a possible risk of Type II statistical error. The 
follow-up period was intermediate, and longer follow-up 
periods will be required for the further validation of the 
effect of preventive hemoclip closure. Third, the amount 
of intraoperative blood loss might fluctuate according to 
cardiotomy suction and RBC salvage during CPB. Fourth, 
the number of hemoclips was retrospectively counted by 
two surgeons in frontal-view chest X-rays after the LT, 
and three-dimensional computed tomography might be 
more precise for counting. Fifth, this study compared the 
outcomes of preventive hemoclip closure between patients 
with and without PH undergoing LT, but not the outcomes 
in PH patients undergoing LT with and without preventive 
hemoclip use, due to ethical reasons. 
In conclusion, our study suggests that meticulous closure 
of collateral vessels in the perihilar mediastinal pleura 
during LT in patients with primary PH might control 
intraoperative bleeding and be associated with acceptable 
surgical mortality similar to patients undergoing LT for 
other pulmonary diseases.
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